azabicyclo[2.2.2]octane precursors were determined by NMR
spectroscopy and by X-ray analysis. The stereochemical
outcome of ring expansion reactions and the configuration
at carbon C2 could easily be assigned by NOE interactions
of protons H2, H7endo, and H8endo. QCI-based 2R-configured
[3.2.2]-azabicyclic 18b showed strong interactions between
H2 and H7endo, H3 and H4 (4 f 10%). Further evidence for
the equatorial position of the methoxy group was provided
by X-ray analysis of alkyne 18b (Scheme 4).17
ature.19 The double stereochemical label facilitates evaluation
of both leakage from QCI to pseudoenantiomeric QCD and
stereoselectivity of nucleophilic attack of the cation. It is
striking that although a carbocation is involved in our
rearrangement, the configuration at carbon C2 is retained
throughout the reaction, and equilibration between the
postulated QCI and QCD cations is not observed (Scheme
5). We suggest that iminium resonance of the cation is
Scheme 5. Mechanism of Silver-Mediated Ring Expansion via
Pseudoenantiomeric13 Carbocations
Scheme 4. NOE and X-ray Analysis of 18b
accompanied by some pyramidalization of the carbocation.
This has the effect of directing external capture of the
nucleophile to one π-face only. The carbocation of the
quinuclidin-5-one system is more prone to bridge flipping
(weaker C-N iminium bond) than the system with vinyl side
chain (stronger C-N iminium bond). The nucleophilic shift
of C3 from C2 to C9 is stereoelectronically favored if the
migrating C2-C3 bond is antiperiplanar to the C9-X bond
as well as to the nitrogen lone pair. The crystal structure of
a C9-brominated QCD analogue which is similar to iodo-
methyl precursor 15 fulfills the criterion of antiperiplanarity,
with torsion angle Φ (C3-C2-C9-X) ) 166.5°.20
Conclusion. A simple stereoselective one-pot synthesis
of a new class of azabicycles has been accomplished.
Currently, more than a dozen of the title azabicyclics have
been prepared. They are of potential therapeutic and phar-
maceutical interest. In addition, functionalized and substituted
forms of these compounds should be useful as building
blocks for asymmetric synthesis. The rearrangement proceeds
under mild SN1-like conditions and tolerates additional
functionalities such as carbonyl and ester groups and alkynes.
After optimization, no crossover from the QCI into the QCD
series and vice versa occurs. Preliminary evaluation of
biological activity suggests that our [3.2.2]-azabicyclics are
nontoxic,21 unlike quinidine and anatoxin-a.
Throughout our experiments QCI consistently gave higher
yields of ring-expanded azabicycles than the corresponding
QCD derivatives. We attribute this to interference of the C5-
side chain with the emerging ring-expanded system. The
mechanism of the silver salt-mediated rearrangement is
assumed to involve a nucleophilic shift of C3 from C2 to
C9 to generate a strained, nonplanar iminium ion instead of
an aziridinium ion which is reported to be the key intermedi-
ate in various rearrangements of â-amino alcohols such as
the ring enlargement of an L-proline derivative in the
synthesis of (-)-pseudoconhydrine.18 Bicyclic systems with
strained bridgehead imine double bonds (E and Z isomers)
have been obtained in a matrix in the dark at low temper-
(15) Schrake, O.; Braje, W. M.; Hoffmann, H. M. R.; Wartchow, R.
Tetrahedron: Asymmetry 1998, 9, 3717. Braje, W. M.; Frackenpohl, J.;
Schrake, O.; Wartchow, R.; Beil, W.; Hoffmann, H. M. R. HelV. Chim.
Acta 2000, 83, 777.
(16) Frackenpohl, J. Ph.D. Thesis, University Hannover, 2000. Braje,
W. M. Ph.D. Thesis, University Hannover, 1999.
(17) Wartchow, R.; Frackenpohl, J.; Ro¨per, S.; Hoffmann, H. M. R.
Z. Kristallogr. NCS 2000, 215, in press. Norrby, P.-O.; Kolb, H. C.;
Sharpless, K. B. J. Am. Chem. Soc. 1994, 116, 8470. Wartchow, R.; Schrake,
O.; Braje, W. M.; Hoffmann, H. M. R. Z. Kristallogr. NCS 1999, 214, 285.
von Riesen, C.; Wartchow, R.; Hoffmann, H. M. R. Z. Kristallogr. NCS
1998, 213, 483.
(18) Wilken, J.; Kossenjans, M.; Saak, W.; Haase, D.; Pohl, S.; Martens,
J. Liebigs Ann./Recueil 1997, 573. Cossy, J.; Dumas, C.; Pardo, D. G. Eur.
J. Org. Chem. 1999, 1693.
(19) Sheridan, R. S.; Ganzer, G. A. J. Am. Chem. Soc. 1983, 105, 6158.
Radziszewski, J. G.; Downing, J. W.; Wentrup, C.; Kaszynski, P.;
Jawdosiuk, M.; Kovacic, P.; Michl, J. J. Am. Chem. Soc. 1985, 107, 2799.
(20) Wartchow, R.; Frackenpohl, J.; Hoffmann, H. M. R. Submitted.
Braje, W. M.; Wartchow, R.; Hoffmann, H. M. R. Angew. Chem. 1999,
111, 2698; Angew. Chem., Int. Ed. 1999, 38, 2540.
(21) See Supporting Information and Wagner, S.; Beil, W.; Mai, U. E.
H.; Bokemeyer, C.; Meyer, H. J.; Manns, M. P. Pharmacology 1994, 49,
226.
Acknowledgment. We thank the Deutsche Forschungs-
gemeinschaft (S.R.), the Fonds der Chemischen Industrie
(J.F.), and Graduiertenfo¨rderung des Landes Niedersachsen
(O.S.) for Ph.D. fellowships, Buchler GmbH Braunschweig
for a generous gift of QCI and QCD, Stefan Neumann for
experimental contributions, and Lars Ole Haustedt, Ulrike
Eggert, and Thomas Dane for their help.
Supporting Information Available: X-ray data for 18b
and spectroscopic data for each new compound. This material
OL0057378
1664
Org. Lett., Vol. 2, No. 12, 2000